Antibodies News and Research

RSS
Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Pharmacies are turning away immunocompromised patients seeking 4th covid shot

Pharmacies are turning away immunocompromised patients seeking 4th covid shot

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

Evaluation of cross-reactive T cell responses between SARS-CoV-2 and common-cold human coronaviruses

Evaluation of cross-reactive T cell responses between SARS-CoV-2 and common-cold human coronaviruses

Sensitivity and specificity of a “spit and mail” SARS-CoV-2 serology test

Sensitivity and specificity of a “spit and mail” SARS-CoV-2 serology test

LA County study finds COVID-19 'herd immunity' unlikely

LA County study finds COVID-19 'herd immunity' unlikely

Neurological complications of the SARS-CoV-2 vaccine

Neurological complications of the SARS-CoV-2 vaccine

Current vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2 variants

Current vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2 variants

Constructing SARS-CoV-2 virus-like particles in tobacco plants for vaccine development

Constructing SARS-CoV-2 virus-like particles in tobacco plants for vaccine development

Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

Blood proteins could be potential targets for future drugs to slow aging process

Blood proteins could be potential targets for future drugs to slow aging process

Short- and long-term systemic responses in the golden hamster following SARS-CoV-2 or influenza A virus infection

Short- and long-term systemic responses in the golden hamster following SARS-CoV-2 or influenza A virus infection

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Prevalence of olfactory dysfunction 18 months after SARS-CoV-2 infection

Prevalence of olfactory dysfunction 18 months after SARS-CoV-2 infection

Study finds stable T-Cell response against Omicron after mRNA booster vaccination

Study finds stable T-Cell response against Omicron after mRNA booster vaccination

Research shows depletion of extracellular vesicles weakens immune response towards SARS-CoV-2

Research shows depletion of extracellular vesicles weakens immune response towards SARS-CoV-2